Akso Health (AHG) Cost of Revenue (2017 - 2019)

Akso Health has reported Cost of Revenue for 3 years, with the latest figure at $9.3 million in Q3 2019.

• For the quarter ending Q3 2019, Cost of Revenue fell 21.14% year-over-year to $9.3 million; the trailing twelve-month figure through Sep 2019 stood at -$1.2 million (down 104.8% YoY), and the FY2025 full-year result was $15.1 million, up 556.98% from the prior year.
• Cost of Revenue for Q3 2019 stood at $9.3 million, up from -$29.4 million in the prior quarter.
• The five-year high for Cost of Revenue was $11.7 million in Q3 2018, with the low at -$29.4 million in Q1 2019.
• Historically, Cost of Revenue has averaged $2.1 million across 3 years, with a median of $5.5 million in 2017.
• Annual changes were most pronounced in 2018 — Cost of Revenue soared 354.15% — and 2019, when it plunged 805.62%.
• Akso Health's Cost of Revenue stood at $5.5 million in 2017, then surged by 30.84% to $7.2 million in 2018, then gained by 29.13% to $9.3 million in 2019.
• The last three Cost of Revenue figures came in at $9.3 million (Q3 2019), -$29.4 million (Q1 2019), and $7.2 million (Q4 2018), per Business Quant data.